Market Access and Reimbursement in Key European Markets and the US
We are delighted to announce that the latest edition of our popular introductory guide: ‘Market Access and Reimbursement in Key European Markets and the US’ is now available. The Petauri Evidence pricing and market access experts have updated the reimbursement routes and added new market insights for 2025/26.
In this introductory guide, our experts present an overview of the reimbursement landscape for pharmaceuticals in:
- France
- United Kingdom
- Germany
- Italy
- Spain
- United States
The guide also includes a look at the European Union’s Joint Clinical Assessment (EU JCA).
Please complete the form below to request your copy of the guide: